Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients.
Nagengast WB, Hooge MN, van Straten EM, Kruijff S, Brouwers AH, den Dunnen WF, de Jong JR, Hollema H, Dierckx RA, Mulder NH, de Vries EG, Hoekstra HJ, Hospers GA. Nagengast WB, et al. Among authors: mulder nh. Eur J Cancer. 2011 Jul;47(10):1595-602. doi: 10.1016/j.ejca.2011.02.009. Epub 2011 Mar 21. Eur J Cancer. 2011. PMID: 21429739
Evaluation of [18F]FHPG as PET tracer for HSVtk gene expression.
de Vries EF, van Dillen IJ, van Waarde A, Willemsen AT, Vaalburg W, Mulder NH, Hospers GA. de Vries EF, et al. Among authors: mulder nh. Nucl Med Biol. 2003 Aug;30(6):651-60. doi: 10.1016/s0969-8051(03)00048-9. Nucl Med Biol. 2003. PMID: 12900291
Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, Hollema H, Boezen HM, Mulder NH, Plukker JT, de Jong S, Kleibeuker JH, Koornstra JJ. van Geelen CM, et al. Among authors: mulder nh. J Clin Oncol. 2006 Nov 1;24(31):4998-5004. doi: 10.1200/JCO.2006.06.8809. J Clin Oncol. 2006. PMID: 17075118
Cell biological markers of drug resistance in ovarian carcinoma.
van der Zee AG, Hollema HH, de Bruijn HW, Willemse PH, Boonstra H, Mulder NH, Aalders JG, de Vries EG. van der Zee AG, et al. Among authors: mulder nh. Gynecol Oncol. 1995 Aug;58(2):165-78. doi: 10.1006/gyno.1995.1205. Gynecol Oncol. 1995. PMID: 7622101 Review.
405 results